Patentability of Chemical Selection Inventions: The Olanzapine and Escitalopram Decisions
The thesis is a response to the recent decisions of the German Federal Court of Justice on the patentability requirements of selection inventions, namely, the Olanzapine and Escitalopram decisions.
Saved in:
Main Author: | Ahn, Hyewon (auth) |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Nomos Verlagsgesellschaft mbH & Co. KG
2011
|
Series: | Munich Intellectual Property Law Center - MIPLC
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patentability Requirements for Nanotechnological Inventions An Approach from the European Patent Convention Perspective
by: Cisneros, Mario
Published: (2009) -
Second Generation Patents in Pharmaceutical Innovation
by: Ahn, Hyewon
Published: (2014) -
Bioethics and the Patent Eligibility of Human Embryonic Stem Cells-Related Inventions in Europe
by: Ugurlu, Ali Seyhan
Published: (2014) -
Patent Strategy in Pharmaceutical Industry: Are additional patents valuable?
by: Donghi, Monica
Published: (2014) -
Patenting Proteomics Patentability and Scope of Protection of Three-Dimensional Protein Structure Claims under German, European and US law
by: Schuster, Martina
Published: (2010)